lipo c con b12 LipoC + (10mL) LIPO-C with B12 10ml –

Example 11: Transdermal Formulation [00352] A compound of Formula I is admixed with a polymer matrix, a permeation enhancer and one or more other excipients

Injectable glutathione is administered directly into the body via IV

This is the safest point to begin to assess tolerance and minimize the risk of side effects

Primary outcome is SRI-4 response, defined as Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) reduction from baseline of 4 points, no worsening in British Isles Lupus Assessment Group 2004, and no worsening in Physician Global Assessment of Disease Activity

Faheem Najeeb Functional & Integrative Medicine Practitioner, Medical Director, Tigris Valley